MICROSAIC SYSTEMS PLC

AGM Information • May 15, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1434F

Microsaic Systems plc

15 May 2017

15 May 2017

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Result of AGM

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that at its Annual General Meeting ("AGM") held on 15 May 2017, all resolutions were duly passed.

Eric Yeatman, Microsaic's Chairman, commented:

"We are grateful for the support of our shareholders at this year's AGM.

"As previously announced, Jim Ramage retires today. The board would like to thank Jim for his contributions to the development of the Company, both as CEO and previously as a Non-Executive Director, and we wish him a very happy retirement. Until a new CEO is selected and in post, the Company will be managed by the executive team of Chief Operating Officer Glenn Tracey and Finance Director Bevan Metcalf, and myself as Non-Executive Chairman."

Enquiries:
Microsaic Systems plc Glenn Tracey, COO Bevan Metcalf, FD	+44 (0) 1483 751577
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong	+44 (0)20 7496 3000
Citigate Dewe Rogerson (Financial PR) Mark Swallow Marine Perrier	+44 (0)20 7638 9571

About Microsaic Systems

Microsaic Systems plc is a high technology company developing chip-based, bench-top mass spectrometry ("MS") instruments that are designed to improve the efficiency of Pharma R&D. MS is an analytical technique of choice for biochemists across many industry sectors.

Microsaic aims to bring routine MS analysis to the pharmaceutical scientist, providing powerful methods of analysis to enable earlier decision making relating to product identification, purity and bioactivity.

The Company is working with established global companies in preparative and purification science with expertise in Pharma and life sciences to co-develop new, integrated and optimised, application-specific, solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.

The Microsaic 4000 MiD®, single quadrupole, is the world's smallest MS system, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. The Company is also developing new MS systems, based on its patented chip technologies, to address further areas of emerging need in Pharma R&D.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in 2011 (ticker: MSYS).

www.microsaic.com 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGAAMMTMBJBBPR